Seller record · Telehealth service

JumpstartMD

By Paul Harris, Standards EditorRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 2 of 8 criteria. S4, compounding disclosure: The semaglutide page offers personalized weight loss medications with the active ingredient semaglutide and does not say they are compounded or not FDA-approved, and the weight loss page advertises FDA-approved GLP-1s. The answers describe compounded weight loss prescriptions without an FDA statement; only the sermorelin and peptide pages say compounded medications are not FDA-approved. 1 more criterion also fails; see the table below.

At a glance

JumpstartMDTelehealth service

6/8criteria passed

Price: Sermorelin $179 a month on a three-month commitment; weight loss membership from $99 a month, medication not included
Sells: Wegovy, oral Wegovy, Zepbound, and 11 more
FDA letters: None on file

Visit JumpstartMD See all eight dispositions

Telehealth service. Passes 6 of 8 criteria. Recorded against Standard v1.1.

A California physician-led weight loss and hormone practice with 14 clinics and online care for California residents, prescribing brand-name GLP-1s, semaglutide and tirzepatide medications and other weight loss drugs inside a monthly membership, plus sermorelin, tesamorelin and hormone therapy.

Operating entity JumpstartMD, Inc.

Dispositions

Code	Criterion	Disposition	Where it appears
S1	Prescriber requirement	PASS	JumpstartMD's website; JumpstartMD's weight loss page
S2	Prescription gating	PASS	JumpstartMD's website; JumpstartMD's weight loss page
S3	Pharmacy identification	PASS	JumpstartMD's FAQ
S4	Compounding disclosure	FAIL	JumpstartMD's weight loss medication semaglutide page; JumpstartMD's weight loss page; JumpstartMD's FAQ
S5	Analytical documentation	FAIL	JumpstartMD's weight loss medications page; JumpstartMD's sermorelin page; JumpstartMD's FAQ
S6	Business address	PASS	JumpstartMD's privacy policy; JumpstartMD's terms of use page
S7	Price disclosure	PASS	JumpstartMD's sermorelin page; JumpstartMD's website
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSA JumpstartMD clinician reviews a 60-biomarker lab panel and the member's history at an initial consultation before building the plan, and prescription treatments are provided only if clinically appropriate. The founder and chief medical officer is named as Sean Bourke, MD.Source: JumpstartMD's website; JumpstartMD's weight loss page.

S2PASSThe steps list a free consultation, then lab work, then a meeting with a clinician who builds the plan, and medication starts only when it is clinically right. The paid first step buys the clinician appointment and the lab panel.Source: JumpstartMD's website; JumpstartMD's weight loss page.

S3PASSThe answers name the compounded medication pharmacy partner that fills and ships compounded prescriptions: PerfectRx, with a phone number. Brand-name prescriptions go to the member's pharmacy of choice.Source: JumpstartMD's FAQ.

S4FAILThe semaglutide page offers personalized weight loss medications with the active ingredient semaglutide and does not say they are compounded or not FDA-approved, and the weight loss page advertises FDA-approved GLP-1s. The answers describe compounded weight loss prescriptions without an FDA statement; only the sermorelin and peptide pages say compounded medications are not FDA-approved.Source: JumpstartMD's weight loss medication semaglutide page; JumpstartMD's weight loss page; JumpstartMD's FAQ.

S5FAILNo certificate of analysis or lot document is published on the medication pages, the peptide pages, the answers or the terms.Source: JumpstartMD's weight loss medications page; JumpstartMD's sermorelin page; JumpstartMD's FAQ.

S6PASSJumpstartMD, Inc. at 350 Lorton Avenue, Burlingame, CA 94010, printed in the footer of every page and as the contact address in the privacy policy. The terms name California law.Source: JumpstartMD's privacy policy; JumpstartMD's terms of use page.

S7PASSSermorelin costs $179 a month on a three-month commitment, with the three-month supply, clinician evaluation and monitoring included. The weight loss assessment, with a clinician appointment and lab panel, costs $49 on a limited-time offer beside a struck-through $379, and the weight loss membership then costs $99 a month online or $199 in clinic. Medication is not included in the membership, and no GLP-1 medication price is printed.Source: JumpstartMD's sermorelin page; JumpstartMD's website.

S8PASSNo FDA warning letter names JumpstartMD or JumpstartMD, Inc., and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: Wegovy, oral Wegovy, Zepbound, Ozempic, Mounjaro, Rybelsus, Foundayo, semaglutide weight loss medications, tirzepatide weight loss medications, phentermine, Contrave, sermorelin, tesamorelin, hormone replacement therapy.

Other sellers of the same products

Who sells semaglutide Who sells tirzepatide Who sells sermorelin Who sells tesamorelin

Visit JumpstartMD

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.